Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets.
about
AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular dataImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseAssessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradomeIdentification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapyThe contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research.T cell recognition of naturally presented epitopes of self-heat shock protein 70.For many but not for all: how the conformational flexibility of the peptide/MHCII complex shapes epitope selectionA mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 2-model applications.Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritisDifferent binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoiresThe exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infectionDo MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization.Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCTMajor histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High SpecificityClass II major histocompatibility complex mutant mice to study the germ-line bias of T-cell antigen receptorsToward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools.Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough.High-resolution analysis of the murine MHC class II immunopeptidome.Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells.Reconstruction of a pathway of antigen processing and class II MHC peptide capture.Lymphomas can develop from B cells chronically helped by idiotype-specific T cellsPeptide length significantly influences in vitro affinity for MHC class II molecules.N-terminal flanking residues of a diabetes-associated GAD65 determinant are necessary for activation of antigen-specific T cells in diabetes-resistant mice.Anomalous immunogenic properties of serine proteases.Microcapillary liquid chromatography/tandem mass spectrometry using alkaline pH mobile phases and positive ion detection.Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma.Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility.
P2860
Q21203715-4C38CC74-6FEF-4836-948B-1ED421D56414Q28238379-3E9A103B-A76C-42BE-BAC6-221B5CF42ECBQ28742682-EF066985-F9EC-4FF4-B169-B0DBD9992814Q30437344-BBFE1D43-4F29-4480-936A-C67C484CEE41Q30444065-3531B722-7F68-4863-A189-BF0F2B5E3559Q33393949-351350BF-9628-4610-8591-C50556060B40Q33700807-99A13D56-92F0-4529-BBBB-6401A1AA1791Q34338884-D9355C69-78AC-4839-AF14-17BB954B3271Q34413009-158AC917-70E8-4F0E-A0F6-255F1C1C40FAQ34616781-1676CD33-8BEB-43A1-AC33-4D0EB5EDD885Q34978613-AD5D61B5-07EE-41F5-8628-1C16EDA35F1CQ35821240-6CDD18DC-2BC7-46AD-B2DD-AE2550797B9FQ35903181-7C165A1C-4F39-4A76-BB6B-A0B394CA3C07Q36186533-EE77A8EE-7688-402A-8969-9AAC3764ECC0Q36271068-0D3BCEB5-8A46-480A-8A55-CAEB06D26B63Q36305321-1E1E32EF-E97A-4ADE-A035-57381C4E2709Q36386903-F2E43F55-FE63-4DD0-9BCC-9817238BF434Q36778316-30EC6685-44FB-4FDB-AD6B-9089220806EFQ37281369-459B226E-870C-458E-8E3D-7A56D8F88FDDQ37939072-A7F8C0C3-50ED-468F-9600-F2A501E6143AQ38121075-BEC08F55-3A33-44D3-BFE9-76A4C08ED6F0Q38825612-C5CB8B4E-B13D-4228-9F5F-DAB579415A56Q39175672-52AA5C90-913C-4098-BE03-643CCB98E085Q39474621-C4A2C7C4-A204-419E-9C3E-FF02CE8A9F90Q40151915-5913EB61-CD0E-43A8-A943-7B3EDA06892CQ41982582-5E05D045-91CC-4800-8AC8-93C9796D4470Q42004430-019CD72C-BDAB-40FD-B03F-D6D568547E8DQ42651261-C8F60EE3-09B5-4859-9C7B-614110B9BFD5Q43277065-E841C788-0CA9-4692-B0B7-72A1E693D7C7Q44419639-05FCD8FD-1D6F-403E-AA10-B185CDADF0BDQ49586408-F46BB9C6-1339-4BE3-AF1F-8B980C3CDB1FQ51556710-DA7B7D05-00DF-4434-8763-45611DB0667CQ55067919-7C940DE3-E251-40C4-89C6-23D19680F476
P2860
Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Analysis of MHC class II antig ...... s that constitute nested sets.
@ast
Analysis of MHC class II antig ...... s that constitute nested sets.
@en
type
label
Analysis of MHC class II antig ...... s that constitute nested sets.
@ast
Analysis of MHC class II antig ...... s that constitute nested sets.
@en
prefLabel
Analysis of MHC class II antig ...... s that constitute nested sets.
@ast
Analysis of MHC class II antig ...... s that constitute nested sets.
@en
P2093
P1476
Analysis of MHC class II antig ...... s that constitute nested sets.
@en
P2093
Chance J Luckey
Donald F Hunt
Forest M White
Jarrod A Marto
John D Lippolis
Timothy N J Bullock
Victor H Engelhard
P304
P356
10.4049/JIMMUNOL.169.9.5089
P407
P577
2002-11-01T00:00:00Z